Comparing the current results to its competitors, Sharps Technology Inc reported Revenue increase in the 2 quarter 2026 by 0 % year on year. The revenue growth was below Sharps Technology Inc 's competitors' average revenue growth of 13.71 %, achieved in the same quarter.
Sharps Technology Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 38.85 %
June 5, 2024
Sharps Technology Strengthens Position in Pre-Fillable Syringe Industry with Key Acquisitions and Worldwide Sales AgreementIn a significant move to solidify its presence in the pre-fillable syringe (PFS) market, Sharps Technology has made substantial strides with a series of acquisitions and strategic partnerships. The company, known for its commitment to safe and innovative drug delivery systems, has cemented its standing as a major player in the industry.The first major milestone in this strategic progression was the acquisition of InjectEZ, which has allowed Sharps Technology to establish its position in the PFS industry in the United States. To secure the purchase exclusivity, the company made a deposit ...
March 7, 2024
In a groundbreaking move, Sharps Technology and Roncadelle Operations have recently announced a worldwide sales and distribution agreement for their innovative portfolio of safe technology drug delivery systems. This collaboration aims to expand the market reach of both companies while ensuring the widespread availability of their secure and disposable smart safety syringes Securegard, SAFER, and Sologard lines.This strategic partnership is set to have a significant impact on both Sharps Technology and Roncadelle Operations, as they combine their expertise and resources to tackle the growing need for safer medical practices worldwide. By joining forces, these industry leaders can now offer a comprehensive ...
February 21, 2024
In a significant development for the healthcare industry, Sharps Technology, a leading provider of innovative medical devices, has made its entry into the Latin American market. The company has received its initial orders for its revolutionary Securegard Disposable Smart Safety Syringes from a strategic distribution partner in Colombia. This marks a major milestone for Sharps Technology as it expands its presence in the region and introduces a line of competitively priced, low waste, and smart safety syringes to the Colombian healthcare system and the wider Latin American market.The first orders for Sharps Securegard syringes, available in 1mL and 3mL variants, are currently in process. The introduction of ...
Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.
Retractable Technologies Inc. is a medical device manufacturing company that specializes in the production of retractable needle systems. Their business model revolves around developing and distributing innovative safety medical products that protect healthcare workers from accidental needlestick injuries. By offering a range of retractable needle solutions, they aim to improve workplace safety and reduce the potential transmission of bloodborne diseases.
Sources:
Sharps Technology Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Sharps Technology Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
